Phase II study of AZD4547 in patients with tumors harboring aberrations in the FGFR pathway: Results from the NCI-MATCH Trial (EAY131) subprotocol W

Young K. Chae, Fangxin Hong, Christos Vaklavas, Heather H. Cheng, Peter Hammerman, Edith P. Mitchell, James A. Zwiebel, S. Percy Ivy, Robert J. Gray, Shuli Li, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Stanley R. Hamilton, Aaron Mansfield, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'DwyerAlice P. Chen, Keith T. Flaherty

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of AZD4547 in patients with tumors harboring aberrations in the FGFR pathway: Results from the NCI-MATCH Trial (EAY131) subprotocol W'. Together they form a unique fingerprint.

Medicine & Life Sciences